aluates Reports

$ 0.0

Automative

Global Diagnostic Antibodies Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-15H13481

Global Diagnostic Antibodies Market Research Report 2023

BUY CHAPTERS

Global Diagnostic Antibodies Market Research Report 2025

Code: QYRE-Auto-15H13481

Report

January 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Aytu BioScience, Inc.

Agilent Technologies Inc

Abbott

Abcam

Boehringer Ingelheim International GmbH

Bio-Rad Laboratories Inc

Roche Holding AG

Thermo Fisher Scientific

Merck KGaA

Beckman Coulter

Novus Biologicals

Cell Signaling Technology

Diagnostic Antibodies Market Size

The global market for Diagnostic Antibodies was valued at US$ 28560 million in the year 2024 and is projected to reach a revised size of US$ 42570 million by 2031, growing at a CAGR of 5.9% during the forecast period.

Diagnostic Antibodies Market

Diagnostic Antibody detection is still the primary approach for confirmation of Lyme borreliosis. Quantitative EIAs (enzyme immune assays) are used as a first-line test with the possibility of supplementary western blotting (WB). Specific antibodies are detectable in serum and in CSF.

The global diagnostic antibodies market refers to the market for antibodies used in diagnostic tests and assays for various diseases and conditions. Diagnostic antibodies play a crucial role in detecting and identifying specific biomarkers or targets in patient samples, aiding in the accurate diagnosis and monitoring of various diseases.

Key factors driving the growth of the global diagnostic antibodies market include:

Increasing prevalence of chronic and infectious diseases: The growing burden of chronic diseases, such as cancer, cardiovascular diseases, and autoimmune disorders, has created a demand for accurate diagnostic tools. Diagnostic antibodies, with their high specificity and sensitivity, enable the detection of disease markers and facilitate early diagnosis and treatment.

Advancements in personalized medicine: The shift towards personalized medicine, where treatments are tailored to an individual’s specific characteristics and needs, has increased the demand for precise diagnostic tools. Diagnostic antibodies offer the ability to identify specific biomarkers associated with diseases, enabling personalized treatment strategies.

Technological advancements in antibody production: The development of advanced techniques for antibody production, such as recombinant DNA technology and phage display technology, has revolutionized the diagnostic antibodies market. These technologies allow for the production of highly specific and reproducible antibodies, enhancing the accuracy of diagnostic tests.

Growing demand for point-of-care testing: Point-of-care testing (POCT) has gained significant popularity due to its convenience and rapid results. Diagnostic antibodies are essential components of many POCT devices, enabling on-site diagnosis and immediate treatment decisions.

Increasing healthcare expenditure and focus on early diagnosis: With rising healthcare expenditures and a growing emphasis on preventive healthcare, there is a greater focus on early disease detection. Diagnostic antibodies aid in the early diagnosis of diseases, enabling timely intervention and improved patient outcomes.

The global diagnostic antibodies market is highly competitive, with several key players dominating the market. These include Thermo Fisher Scientific, Abcam plc, Bio-Rad Laboratories, Inc., Merck KGaA, and Beckman Coulter, among others. These companies are actively engaged in research and development activities to develop innovative diagnostic antibodies and expand their product portfolios.

In summary, the global diagnostic antibodies market is driven by the increasing prevalence of chronic and infectious diseases, advancements in personalized medicine, technological advancements in antibody production, growing demand for point-of-care testing, and the focus on early diagnosis. The market is expected to witness further growth as the demand for accurate and reliable diagnostic tools continues to rise.

This report aims to provide a comprehensive presentation of the global market for Diagnostic Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Antibodies.

The Diagnostic Antibodies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diagnostic Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Diagnostic Antibodies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Diagnostic Antibodies Market Report

Report Metric	Details
Report Name	Diagnostic Antibodies Market
Accounted market size in year	US$ 28560 million
Forecasted market size in 2031	US$ 42570 million
CAGR	5.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Monoclonal Antibodies polyclonal Antibodies Recombinant Polyclonal Antibodies Others
Segment by Application	Hospitals Diagnostic Centre Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Aytu BioScience, Inc., Agilent Technologies, Inc., Abbott, Abcam plc., Boehringer Ingelheim International GmbH, Bio-Rad Laboratories, Inc., Roche Holding AG, Thermo Fisher Scientific, Merck KGaA, Beckman Coulter, Novus Biologicals, Cell Signaling Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnostic Antibodies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Diagnostic Antibodies Market growing?

Ans: The Diagnostic Antibodies Market witnessing a CAGR of 5.9% during the forecast period 2025-2031.

What is the Diagnostic Antibodies Market size in 2031?

Ans: The Diagnostic Antibodies Market size in 2031 will be US$ 42570 million.

Who are the main players in the Diagnostic Antibodies Market report?

Ans: The main players in the Diagnostic Antibodies Market are Aytu BioScience, Inc., Agilent Technologies, Inc., Abbott, Abcam plc., Boehringer Ingelheim International GmbH, Bio-Rad Laboratories, Inc., Roche Holding AG, Thermo Fisher Scientific, Merck KGaA, Beckman Coulter, Novus Biologicals, Cell Signaling Technology

What are the Application segmentation covered in the Diagnostic Antibodies Market report?

Ans: The Applications covered in the Diagnostic Antibodies Market report are Hospitals, Diagnostic Centre, Others

What are the Type segmentation covered in the Diagnostic Antibodies Market report?

Ans: The Types covered in the Diagnostic Antibodies Market report are Monoclonal Antibodies, polyclonal Antibodies, Recombinant Polyclonal Antibodies, Others

Recommended Reports

Antibody Markets

Diagnostics Testing

Infectious Disease

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Diagnostic Antibodies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Monoclonal Antibodies

1.2.3 polyclonal Antibodies

1.2.4 Recombinant Polyclonal Antibodies

1.2.5 Others

1.3 Market by Application

1.3.1 Global Diagnostic Antibodies Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Diagnostic Centre

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Diagnostic Antibodies Market Perspective (2020-2031)

2.2 Global Diagnostic Antibodies Growth Trends by Region

2.2.1 Global Diagnostic Antibodies Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Diagnostic Antibodies Historic Market Size by Region (2020-2025)

2.2.3 Diagnostic Antibodies Forecasted Market Size by Region (2026-2031)

2.3 Diagnostic Antibodies Market Dynamics

2.3.1 Diagnostic Antibodies Industry Trends

2.3.2 Diagnostic Antibodies Market Drivers

2.3.3 Diagnostic Antibodies Market Challenges

2.3.4 Diagnostic Antibodies Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Diagnostic Antibodies Players by Revenue

3.1.1 Global Top Diagnostic Antibodies Players by Revenue (2020-2025)

3.1.2 Global Diagnostic Antibodies Revenue Market Share by Players (2020-2025)

3.2 Global Diagnostic Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Diagnostic Antibodies Revenue

3.4 Global Diagnostic Antibodies Market Concentration Ratio

3.4.1 Global Diagnostic Antibodies Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Antibodies Revenue in 2024

3.5 Global Key Players of Diagnostic Antibodies Head office and Area Served

3.6 Global Key Players of Diagnostic Antibodies, Product and Application

3.7 Global Key Players of Diagnostic Antibodies, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Diagnostic Antibodies Breakdown Data by Type

4.1 Global Diagnostic Antibodies Historic Market Size by Type (2020-2025)

4.2 Global Diagnostic Antibodies Forecasted Market Size by Type (2026-2031)

5 Diagnostic Antibodies Breakdown Data by Application

5.1 Global Diagnostic Antibodies Historic Market Size by Application (2020-2025)

5.2 Global Diagnostic Antibodies Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Diagnostic Antibodies Market Size (2020-2031)

6.2 North America Diagnostic Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Diagnostic Antibodies Market Size by Country (2020-2025)

6.4 North America Diagnostic Antibodies Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Diagnostic Antibodies Market Size (2020-2031)

7.2 Europe Diagnostic Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Diagnostic Antibodies Market Size by Country (2020-2025)

7.4 Europe Diagnostic Antibodies Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Diagnostic Antibodies Market Size (2020-2031)

8.2 Asia-Pacific Diagnostic Antibodies Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Diagnostic Antibodies Market Size by Region (2020-2025)

8.4 Asia-Pacific Diagnostic Antibodies Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Diagnostic Antibodies Market Size (2020-2031)

9.2 Latin America Diagnostic Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Diagnostic Antibodies Market Size by Country (2020-2025)

9.4 Latin America Diagnostic Antibodies Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Diagnostic Antibodies Market Size (2020-2031)

10.2 Middle East & Africa Diagnostic Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Diagnostic Antibodies Market Size by Country (2020-2025)

10.4 Middle East & Africa Diagnostic Antibodies Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Aytu BioScience, Inc.

11.1.1 Aytu BioScience, Inc. Company Details

11.1.2 Aytu BioScience, Inc. Business Overview

11.1.3 Aytu BioScience, Inc. Diagnostic Antibodies Introduction

11.1.4 Aytu BioScience, Inc. Revenue in Diagnostic Antibodies Business (2020-2025)

11.1.5 Aytu BioScience, Inc. Recent Development

11.2 Agilent Technologies, Inc.

11.2.1 Agilent Technologies, Inc. Company Details

11.2.2 Agilent Technologies, Inc. Business Overview

11.2.3 Agilent Technologies, Inc. Diagnostic Antibodies Introduction

11.2.4 Agilent Technologies, Inc. Revenue in Diagnostic Antibodies Business (2020-2025)

11.2.5 Agilent Technologies, Inc. Recent Development

11.3 Abbott

11.3.1 Abbott Company Details

11.3.2 Abbott Business Overview

11.3.3 Abbott Diagnostic Antibodies Introduction

11.3.4 Abbott Revenue in Diagnostic Antibodies Business (2020-2025)

11.3.5 Abbott Recent Development

11.4 Abcam plc.

11.4.1 Abcam plc. Company Details

11.4.2 Abcam plc. Business Overview

11.4.3 Abcam plc. Diagnostic Antibodies Introduction

11.4.4 Abcam plc. Revenue in Diagnostic Antibodies Business (2020-2025)

11.4.5 Abcam plc. Recent Development

11.5 Boehringer Ingelheim International GmbH

11.5.1 Boehringer Ingelheim International GmbH Company Details

11.5.2 Boehringer Ingelheim International GmbH Business Overview

11.5.3 Boehringer Ingelheim International GmbH Diagnostic Antibodies Introduction

11.5.4 Boehringer Ingelheim International GmbH Revenue in Diagnostic Antibodies Business (2020-2025)

11.5.5 Boehringer Ingelheim International GmbH Recent Development

11.6 Bio-Rad Laboratories, Inc.

11.6.1 Bio-Rad Laboratories, Inc. Company Details

11.6.2 Bio-Rad Laboratories, Inc. Business Overview

11.6.3 Bio-Rad Laboratories, Inc. Diagnostic Antibodies Introduction

11.6.4 Bio-Rad Laboratories, Inc. Revenue in Diagnostic Antibodies Business (2020-2025)

11.6.5 Bio-Rad Laboratories, Inc. Recent Development

11.7 Roche Holding AG

11.7.1 Roche Holding AG Company Details

11.7.2 Roche Holding AG Business Overview

11.7.3 Roche Holding AG Diagnostic Antibodies Introduction

11.7.4 Roche Holding AG Revenue in Diagnostic Antibodies Business (2020-2025)

11.7.5 Roche Holding AG Recent Development

11.8 Thermo Fisher Scientific

11.8.1 Thermo Fisher Scientific Company Details

11.8.2 Thermo Fisher Scientific Business Overview

11.8.3 Thermo Fisher Scientific Diagnostic Antibodies Introduction

11.8.4 Thermo Fisher Scientific Revenue in Diagnostic Antibodies Business (2020-2025)

11.8.5 Thermo Fisher Scientific Recent Development

11.9 Merck KGaA

11.9.1 Merck KGaA Company Details

11.9.2 Merck KGaA Business Overview

11.9.3 Merck KGaA Diagnostic Antibodies Introduction

11.9.4 Merck KGaA Revenue in Diagnostic Antibodies Business (2020-2025)

11.9.5 Merck KGaA Recent Development

11.10 Beckman Coulter

11.10.1 Beckman Coulter Company Details

11.10.2 Beckman Coulter Business Overview

11.10.3 Beckman Coulter Diagnostic Antibodies Introduction

11.10.4 Beckman Coulter Revenue in Diagnostic Antibodies Business (2020-2025)

11.10.5 Beckman Coulter Recent Development

11.11 Novus Biologicals

11.11.1 Novus Biologicals Company Details

11.11.2 Novus Biologicals Business Overview

11.11.3 Novus Biologicals Diagnostic Antibodies Introduction

11.11.4 Novus Biologicals Revenue in Diagnostic Antibodies Business (2020-2025)

11.11.5 Novus Biologicals Recent Development

11.12 Cell Signaling Technology

11.12.1 Cell Signaling Technology Company Details

11.12.2 Cell Signaling Technology Business Overview

11.12.3 Cell Signaling Technology Diagnostic Antibodies Introduction

11.12.4 Cell Signaling Technology Revenue in Diagnostic Antibodies Business (2020-2025)

11.12.5 Cell Signaling Technology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Aytu BioScience, Inc.

Agilent Technologies Inc

Abbott

Abcam

Boehringer Ingelheim International GmbH

Bio-Rad Laboratories Inc

Roche Holding AG

Thermo Fisher Scientific

Merck KGaA

Beckman Coulter

Novus Biologicals

Cell Signaling Technology

List of Tables

Table 1. Global Diagnostic Antibodies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of polyclonal Antibodies

Table 4. Key Players of Recombinant Polyclonal Antibodies

Table 5. Key Players of Others

Table 6. Global Diagnostic Antibodies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Diagnostic Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Diagnostic Antibodies Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Diagnostic Antibodies Market Share by Region (2020-2025)

Table 10. Global Diagnostic Antibodies Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Diagnostic Antibodies Market Share by Region (2026-2031)

Table 12. Diagnostic Antibodies Market Trends

Table 13. Diagnostic Antibodies Market Drivers

Table 14. Diagnostic Antibodies Market Challenges

Table 15. Diagnostic Antibodies Market Restraints

Table 16. Global Diagnostic Antibodies Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Diagnostic Antibodies Market Share by Players (2020-2025)

Table 18. Global Top Diagnostic Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Antibodies as of 2024)

Table 19. Ranking of Global Top Diagnostic Antibodies Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Diagnostic Antibodies Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Diagnostic Antibodies, Headquarters and Area Served

Table 22. Global Key Players of Diagnostic Antibodies, Product and Application

Table 23. Global Key Players of Diagnostic Antibodies, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Diagnostic Antibodies Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Diagnostic Antibodies Revenue Market Share by Type (2020-2025)

Table 27. Global Diagnostic Antibodies Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Diagnostic Antibodies Revenue Market Share by Type (2026-2031)

Table 29. Global Diagnostic Antibodies Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Diagnostic Antibodies Revenue Market Share by Application (2020-2025)

Table 31. Global Diagnostic Antibodies Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Diagnostic Antibodies Revenue Market Share by Application (2026-2031)

Table 33. North America Diagnostic Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Diagnostic Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Diagnostic Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Diagnostic Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Diagnostic Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Diagnostic Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Diagnostic Antibodies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Diagnostic Antibodies Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Diagnostic Antibodies Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Diagnostic Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Diagnostic Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Diagnostic Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Diagnostic Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Diagnostic Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Diagnostic Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 48. Aytu BioScience, Inc. Company Details

Table 49. Aytu BioScience, Inc. Business Overview

Table 50. Aytu BioScience, Inc. Diagnostic Antibodies Product

Table 51. Aytu BioScience, Inc. Revenue in Diagnostic Antibodies Business (2020-2025) & (US$ Million)

Table 52. Aytu BioScience, Inc. Recent Development

Table 53. Agilent Technologies, Inc. Company Details

Table 54. Agilent Technologies, Inc. Business Overview

Table 55. Agilent Technologies, Inc. Diagnostic Antibodies Product

Table 56. Agilent Technologies, Inc. Revenue in Diagnostic Antibodies Business (2020-2025) & (US$ Million)

Table 57. Agilent Technologies, Inc. Recent Development

Table 58. Abbott Company Details

Table 59. Abbott Business Overview

Table 60. Abbott Diagnostic Antibodies Product

Table 61. Abbott Revenue in Diagnostic Antibodies Business (2020-2025) & (US$ Million)

Table 62. Abbott Recent Development

Table 63. Abcam plc. Company Details

Table 64. Abcam plc. Business Overview

Table 65. Abcam plc. Diagnostic Antibodies Product

Table 66. Abcam plc. Revenue in Diagnostic Antibodies Business (2020-2025) & (US$ Million)

Table 67. Abcam plc. Recent Development

Table 68. Boehringer Ingelheim International GmbH Company Details

Table 69. Boehringer Ingelheim International GmbH Business Overview

Table 70. Boehringer Ingelheim International GmbH Diagnostic Antibodies Product

Table 71. Boehringer Ingelheim International GmbH Revenue in Diagnostic Antibodies Business (2020-2025) & (US$ Million)

Table 72. Boehringer Ingelheim International GmbH Recent Development

Table 73. Bio-Rad Laboratories, Inc. Company Details

Table 74. Bio-Rad Laboratories, Inc. Business Overview

Table 75. Bio-Rad Laboratories, Inc. Diagnostic Antibodies Product

Table 76. Bio-Rad Laboratories, Inc. Revenue in Diagnostic Antibodies Business (2020-2025) & (US$ Million)

Table 77. Bio-Rad Laboratories, Inc. Recent Development

Table 78. Roche Holding AG Company Details

Table 79. Roche Holding AG Business Overview

Table 80. Roche Holding AG Diagnostic Antibodies Product

Table 81. Roche Holding AG Revenue in Diagnostic Antibodies Business (2020-2025) & (US$ Million)

Table 82. Roche Holding AG Recent Development

Table 83. Thermo Fisher Scientific Company Details

Table 84. Thermo Fisher Scientific Business Overview

Table 85. Thermo Fisher Scientific Diagnostic Antibodies Product

Table 86. Thermo Fisher Scientific Revenue in Diagnostic Antibodies Business (2020-2025) & (US$ Million)

Table 87. Thermo Fisher Scientific Recent Development

Table 88. Merck KGaA Company Details

Table 89. Merck KGaA Business Overview

Table 90. Merck KGaA Diagnostic Antibodies Product

Table 91. Merck KGaA Revenue in Diagnostic Antibodies Business (2020-2025) & (US$ Million)

Table 92. Merck KGaA Recent Development

Table 93. Beckman Coulter Company Details

Table 94. Beckman Coulter Business Overview

Table 95. Beckman Coulter Diagnostic Antibodies Product

Table 96. Beckman Coulter Revenue in Diagnostic Antibodies Business (2020-2025) & (US$ Million)

Table 97. Beckman Coulter Recent Development

Table 98. Novus Biologicals Company Details

Table 99. Novus Biologicals Business Overview

Table 100. Novus Biologicals Diagnostic Antibodies Product

Table 101. Novus Biologicals Revenue in Diagnostic Antibodies Business (2020-2025) & (US$ Million)

Table 102. Novus Biologicals Recent Development

Table 103. Cell Signaling Technology Company Details

Table 104. Cell Signaling Technology Business Overview

Table 105. Cell Signaling Technology Diagnostic Antibodies Product

Table 106. Cell Signaling Technology Revenue in Diagnostic Antibodies Business (2020-2025) & (US$ Million)

Table 107. Cell Signaling Technology Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Diagnostic Antibodies Picture

Figure 2. Global Diagnostic Antibodies Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Diagnostic Antibodies Market Share by Type: 2024 VS 2031

Figure 4. Monoclonal Antibodies Features

Figure 5. polyclonal Antibodies Features

Figure 6. Recombinant Polyclonal Antibodies Features

Figure 7. Others Features

Figure 8. Global Diagnostic Antibodies Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Diagnostic Antibodies Market Share by Application: 2024 VS 2031

Figure 10. Hospitals Case Studies

Figure 11. Diagnostic Centre Case Studies

Figure 12. Others Case Studies

Figure 13. Diagnostic Antibodies Report Years Considered

Figure 14. Global Diagnostic Antibodies Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Diagnostic Antibodies Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Diagnostic Antibodies Market Share by Region: 2024 VS 2031

Figure 17. Global Diagnostic Antibodies Market Share by Players in 2024

Figure 18. Global Top Diagnostic Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Antibodies as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Diagnostic Antibodies Revenue in 2024

Figure 20. North America Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Diagnostic Antibodies Market Share by Country (2020-2031)

Figure 22. United States Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Diagnostic Antibodies Market Share by Country (2020-2031)

Figure 26. Germany Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Diagnostic Antibodies Market Share by Region (2020-2031)

Figure 34. China Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Diagnostic Antibodies Market Share by Country (2020-2031)

Figure 42. Mexico Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Diagnostic Antibodies Market Share by Country (2020-2031)

Figure 46. Turkey Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Diagnostic Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Aytu BioScience, Inc. Revenue Growth Rate in Diagnostic Antibodies Business (2020-2025)

Figure 50. Agilent Technologies, Inc. Revenue Growth Rate in Diagnostic Antibodies Business (2020-2025)

Figure 51. Abbott Revenue Growth Rate in Diagnostic Antibodies Business (2020-2025)

Figure 52. Abcam plc. Revenue Growth Rate in Diagnostic Antibodies Business (2020-2025)

Figure 53. Boehringer Ingelheim International GmbH Revenue Growth Rate in Diagnostic Antibodies Business (2020-2025)

Figure 54. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Diagnostic Antibodies Business (2020-2025)

Figure 55. Roche Holding AG Revenue Growth Rate in Diagnostic Antibodies Business (2020-2025)

Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Diagnostic Antibodies Business (2020-2025)

Figure 57. Merck KGaA Revenue Growth Rate in Diagnostic Antibodies Business (2020-2025)

Figure 58. Beckman Coulter Revenue Growth Rate in Diagnostic Antibodies Business (2020-2025)

Figure 59. Novus Biologicals Revenue Growth Rate in Diagnostic Antibodies Business (2020-2025)

Figure 60. Cell Signaling Technology Revenue Growth Rate in Diagnostic Antibodies Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Lyme Disease IgG ELISA Kit Market Research Report 2024

Global Borrelia Burgdorferi Test Kit Market Research Report 2024

Global Lyme Disease Diagnostic Devices Market Research Report 2024

Global Lyme Disease Testing Market Research Report 2025

Enzyme linked Immunoassay Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lyme Disease Test Kit Market Research Report 2025

Global Lyme Disease Diagnostic Service Market Research Report 2025

Global Antigen and AntibodY for Diagnostic Market Research Report 2025

Global Enzyme linked Immunodiagnostic Reagents Market Research Report 2024

Global Western Blotting Antibodies Market Research Report 2024

Global ELISA Kits Market Research Report 2025

Global Allergen Diagnostic Tests Market Research Report 2025

Global Bacteria Test Kit Market Research Report 2024

Global Western Blot Imagers Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global IL1B ELISA Kit Market Research Report 2024

Global Brucella ELISA Kits Market Research Report 2024

Global Lyme Disease Vaccine Market Research Report 2025

Global Rapid Antigen and Antibody Detection Kits Market Research Report 2025

Global Lysozyme Antibody Market Research Report 2025

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19Z7671

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10V14317

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10O5919

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4I19963

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions